Proxy Voting Records Glossary

Fidelity Advisor Biotechnology Fund For the 12 month period: Jul 1, 2007 and Jun 30, 2008 ALEXION PHARMACEUTICALS, INC. Meeting Type: Annual Ticker: ALXN Security ID: 015351109 Meeting Date: May 9, 2008 Proposed by: Management Back to Meetings # Proposal Management Recommendation Vote 1.1 ELECT LEONARD BELL AS A DIRECTOR For For 1.2 ELECT DAVID W. KEISER AS A DIRECTOR For For 1.3 ELECT MAX LINK AS A DIRECTOR For For 1.4 ELECT JOSEPH A. MADRI AS A DIRECTOR For For 1.5 ELECT LARRY L. MATHIS AS A DIRECTOR For For 1.6 ELECT R. DOUGLAS NORBY AS A DIRECTOR For For 1.7 ELECT ALVIN S. PARVEN AS A DIRECTOR For For 1.8 ELECT RUEDI E. WAEGER AS A DIRECTOR For For 2 APPROVAL OF THE AMENDMENT TO 2004 INCENTIVE PLAN, AS DESCRIBED IN THE ACCOMPANYING PROXY STATEMENT, INCLUDING TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK AVAILABLE FOR ISSUANCE BY 2.4 MILLION SHARES (SUBJECT TO ADJUSTMENT IN THE EVENT OF STOCK SPLITS AND OTHER SIMILAR EVENTS). For For 3 RATIFICATION OF APPOINTMENT BY THE BOARD OF DIRECTORS OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. For For     Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. © Copyright 1998-2009 FMR LLC. All rights reserved. Terms of Use  Privacy  Security  Site Map